Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
22%
Ph not_applicable
7
78%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (22.2%)
N/A7 (77.8%)

Trials by Status

unknown111%
recruiting222%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9